Medical AI

A new health program targets the deep-seated care gaps for bilingual women. But is its blend of hybrid care, AI, and cross-border doctors the real revolution?

One orthopedic practice cut 75% of its software by embracing a single AI platform. It's a case study in a powerful trend reshaping specialty medicine.

A federal agency is betting big on an AI-powered wearable that detects internal bleeding, a move set to transform mass casualty care and national preparedness.

Israeli firm Medibyt's FDA-cleared AI platform, CPETWise, slashes diagnostic time by over 50%, promising to make complex heart and lung tests more accessible.

Beyond the pink ribbons, the CIBC Run for the Cure is a funding powerhouse. We unpack the 30-year alliance that's fueling AI-driven diagnostics and policy battles.

A $10M federal contract aims to slash the 7-year wait for rare disease diagnoses. Discover how Probably Genetic's AI and direct-to-patient data are leading the charge.

A series of prestigious awards reveals more than just innovation. It shows how one company's 'Healthcare-grade AI' is delivering real, measurable results.

With healthcare breaches at a four-year high, Novarad's NovaPACS 9.1 update embeds security, AI, and mobile access to protect data and streamline care.

A new report predicts a financial cliff for US health systems. The proposed cure? An AI-driven revolution. But can technology fix a human crisis?

A new breed of AI is tackling healthcare's $360B purchased services black hole. With a key strategic hire, SpendRule aims to prove tech is the cure for waste.

As precision medicine generates a deluge of data, Iylon Oncology's appointment of Dr. Mary Lopresti shows the real value is not in the algorithm, but in human expertise.

With $26M in fresh funding, Metriport is turning fragmented patient data into life-saving clinical intelligence. We decode why AI and open-source are key signals.

In Oregon, a new battery-free sleep apnea implant performed in an AI-powered outpatient center signals a major disruption in surgical delivery and patient access.

With a fresh $17M from investors including CVS Health Ventures, Onos Health is deploying AI to read clinical notes, aiming to untangle the $140B behavioral health market.

Quantum Health is moving beyond navigation, integrating acquisitions to deliver direct care. New C-suite leaders are set to unify this growing empire.

New studies show AI can quantify subtle lung damage, offering hope for earlier, more personalized treatment of Interstitial Lung Disease. What does this mean?

From stroke pioneer to lung disease disruptor, Brainomix's new AI studies signal a major shift in diagnostics. This is the story behind the numbers.

Bay Area Lyme Ventures invests in LymeLess Health's 'Ella' app, an AI tool born from personal struggle, aiming to transform patient care and research.

A new study shows AliveCor's KardiaMobile 6L device nearly doubles arrhythmia detection, signaling a major shift from clinics to patient-led home care.

Low patient enrollment cripples cancer research. Mednet’s new AI tool, TrialMatch, aims to fix this by seamlessly connecting oncologists to vital trials.